Pharma Business Growing At Praxis

The increase is attributed to Praxis’ involvement with new drug launches in conjunction with Food and Drug Administration approvals as well as to increased business in over-the-counter pharmaceutical packaging.

Company president Rick King says Praxis and its network of partners have developed a niche in patient starter kits for new drugs. Managing the starter kits from design and development through to production and fulfillment—it’s an often rapid process—is a key to Praxis’ success in this market, King adds.